As of April 2025, four CD19-directed chimeric antigen receptor (CAR)-T therapies and three CD20-targeting bispecific antibodies (BsAbs) have been US Food and Drug Administration (FDA) approved for the ...
Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...
Borderline personality disorder (BPD) is classified as a severe and persistent mental disorder that causes considerable morbidity and mortality. Roughly 10 percent of people with BPD will die by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results